A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)

Magdalena Hellauer, Stephen Hudson, Julienne Johnson

Research output: Contribution to journalConference Contribution

Abstract

Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy.
Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33% in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation of
patients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulfil these outcomes.

Fingerprint

Pulmonary diseases
Pharmaceutical Services
Chronic Obstructive Pulmonary Disease
Tobacco
Ireland
Pharmaceutical Preparations
Documentation
Cause of Death
Smoking
Incidence

Keywords

  • COPD
  • chronic obstructive pumonary disease
  • smoking

Cite this

Hellauer, Magdalena ; Hudson, Stephen ; Johnson, Julienne. / A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD). In: International Journal of Clinical Pharmacy. 2012 ; Vol. 34, No. 1. pp. 206-206.
@article{d47e26f1f9c246089bb236455fc2df41,
title = "A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)",
abstract = "Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33{\%} in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation ofpatients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulfil these outcomes.",
keywords = "COPD , chronic obstructive pumonary disease , smoking",
author = "Magdalena Hellauer and Stephen Hudson and Julienne Johnson",
year = "2012",
month = "2",
doi = "10.1007/s11096-011-9602-",
language = "English",
volume = "34",
pages = "206--206",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7711",
number = "1",

}

A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD). / Hellauer, Magdalena; Hudson, Stephen; Johnson, Julienne.

In: International Journal of Clinical Pharmacy, Vol. 34, No. 1, 02.2012, p. 206-206.

Research output: Contribution to journalConference Contribution

TY - JOUR

T1 - A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD)

AU - Hellauer, Magdalena

AU - Hudson, Stephen

AU - Johnson, Julienne

PY - 2012/2

Y1 - 2012/2

N2 - Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33% in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation ofpatients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulfil these outcomes.

AB - Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy.Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33% in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation ofpatients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulfil these outcomes.

KW - COPD

KW - chronic obstructive pumonary disease

KW - smoking

U2 - 10.1007/s11096-011-9602-

DO - 10.1007/s11096-011-9602-

M3 - Conference Contribution

VL - 34

SP - 206

EP - 206

JO - International Journal of Clinical Pharmacy

T2 - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7711

IS - 1

ER -